Terms: = Brain cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Prognosis
34 results:
1. Craniopharyngioma in Pediatrics and Adults.
Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
[TBL] [Abstract] [Full Text] [Related]
2. Molecular biological features of cyst wall of adamantinomatous craniopharyngioma.
Zhao C; Wang Y; Liu H; Qi X; Zhou Z; Wang X; Lin Z
Sci Rep; 2023 Feb; 13(1):3049. PubMed ID: 36810626
[TBL] [Abstract] [Full Text] [Related]
3. Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas.
Goschzik T; Mynarek M; Doerner E; Schenk A; Spier I; Warmuth-Metz M; Bison B; Obrecht D; Struve N; Kortmann RD; Schmid M; Aretz S; Rutkowski S; Pietsch T
Acta Neuropathol; 2022 Dec; 144(6):1143-1156. PubMed ID: 36181537
[TBL] [Abstract] [Full Text] [Related]
4. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
Yang H; Wen L; Pan Y; Shan C; Hong W; Wang H; Zhou C; Cai L; Zhou C
BMC Cancer; 2022 May; 22(1):580. PubMed ID: 35614407
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract] [Full Text] [Related]
6. Targeted Therapy in the Management of Modern Craniopharyngiomas.
Reyes M; Taghvaei M; Yu S; Sathe A; Collopy S; Prashant GN; Evans JJ; Karsy M
Front Biosci (Landmark Ed); 2022 Apr; 27(4):136. PubMed ID: 35468695
[TBL] [Abstract] [Full Text] [Related]
7. Recurrent Wnt medulloblastoma treated with marrow-ablative chemotherapy and autologous hematopoietic progenitor cell rescue: a dual case report and review of the literature.
Harris MK; Shatara M; Funk Z; Stanek J; Boué DR; Jones J; Finlay JL; Abdelbaki MS
Childs Nerv Syst; 2022 Feb; 38(2):465-472. PubMed ID: 33948723
[TBL] [Abstract] [Full Text] [Related]
8. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?
Asa SL; Mete O; Ezzat S
Endocr Pathol; 2021 Mar; 32(1):3-16. PubMed ID: 33433883
[TBL] [Abstract] [Full Text] [Related]
9. Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries.
Rocha CRR; Reily Rocha A; Molina Silva M; Rodrigues Gomes L; Teatin Latancia M; Andrade Tomaz M; de Souza I; Karolynne Seregni Monteiro L; Menck CFM
Cells; 2020 Dec; 9(12):. PubMed ID: 33271924
[TBL] [Abstract] [Full Text] [Related]
10. Craniopharyngiomas: A clinicopathological and molecular study of 52 cases - Experience in the Complejo Hospitalario de Toledo and Hospital Universitario 12 de Octubre (Madrid).
Moreno-Torres B; Campos-Martín Y; Meléndez B; Garcia Martin RM; Vicente A; Rodríguez de Lope Á; Alen JF; Mollejo M; Hernández-Laín A
Clin Neuropathol; 2021; 40(1):26-35. PubMed ID: 33040839
[TBL] [Abstract] [Full Text] [Related]
11. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma.
Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I
Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607
[TBL] [Abstract] [Full Text] [Related]
12. miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt/β-catenin signaling pathway.
Tian W; Zhu W; Jiang J
Cell Biol Int; 2020 May; 44(5):1156-1167. PubMed ID: 32009256
[TBL] [Abstract] [Full Text] [Related]
13. Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of ctnnb1-mutated medulloblastomas.
Surun A; Varlet P; Brugières L; Lacour B; Faure-Conter C; Leblond P; Bertozzi-Salomon AI; Berger C; André N; Sariban E; Raimbault S; Prieur F; Desseigne F; Zattara H; Guimbaud R; Polivka M; Delisle MB; Vasiljevic A; Maurage CA; Figarella-Branger D; Coulet F; Guerrini-Rousseau L; Alapetite C; Dufour C; Colas C; Doz F; Bourdeaut F
Neuro Oncol; 2020 Jan; 22(1):128-138. PubMed ID: 31504825
[TBL] [Abstract] [Full Text] [Related]
14. [Implication of BRAF V600E and ctnnb1 gene mutations in the pathological classification of craniopharyngioma].
Xu SS; Wang LM; Zhao LH; He ZL; Gong LP; Lu DH; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):682-687. PubMed ID: 31495087
[No Abstract] [Full Text] [Related]
15. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
[TBL] [Abstract] [Full Text] [Related]
16. Cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive.
Ahmed KI; Govardhan HB; Roy M; Naveen T; Siddanna P; Sridhar P; Suma MN; Nelson N
Indian J Cancer; 2019; 56(1):65-69. PubMed ID: 30950448
[TBL] [Abstract] [Full Text] [Related]
17. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes.
Kang HJ; Oh JH; Chun SM; Kim D; Ryu YM; Hwang HS; Kim SY; An J; Cho EJ; Lee H; Shim JH; Sung CO; Yu E
J Hepatol; 2019 Jul; 71(1):91-103. PubMed ID: 30930222
[TBL] [Abstract] [Full Text] [Related]
18. Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and prognosis of Adamantinomatous Craniopharyngiomas.
Jucá CEB; Colli LM; Martins CS; Campanini ML; Paixão B; Jucá RV; Saggioro FP; de Oliveira RS; Moreira AC; Machado HR; Neder L; Antonini SR; de Castro M
Horm Metab Res; 2018 Jul; 50(7):575-581. PubMed ID: 29625497
[No Abstract] [Full Text] [Related]
19. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.
Cambruzzi E
Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169
[TBL] [Abstract] [Full Text] [Related]
20. TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/β-catenin/snail signaling.
Qiang Z; Jun-Jie L; Hai W; Hong L; Bing-Xi L; Lei C; Wei X; Ya-Wei L; Huang A; Song-Tao Q; Yun-Tao L
Carcinogenesis; 2018 Feb; 39(2):214-224. PubMed ID: 29106517
[TBL] [Abstract] [Full Text] [Related]
[Next]